SMR - Experimental and in silico approaches to target selection and tractability for drug discovery

  • Monday, 21 March 2022, 9:00 AM to 5:00 PM

A one day symposium jointly organised by the Society for Medicines Research (SMR) and the Fine Chemicals Group of the Society for Chemical Industries (SCI) on 21 March 2022 at the Francis Crick Institute, London, UK

The meeting will have two main themes:

  1. Sources of target hypotheses for drug discovery
  2. Practicalities of early assessment of target intervention opportunities

Speakers will include:

  • Lyn Jones (Dana-Farber Cancer Institute, Boston, USA)
  • Jessica Eley (GSK Stevenage, UK)
  • Victor Neduva (MSD, London, UK)
  • Deb Rothman, (Merck, USA)
  • Sarah Teichmann (University of Cambridge, UK)
  • Andrew Leach (EBI, Cambridge, UK)
  • Ian Storer (AstraZeneca, Cambridge, UK)
  • Paul Brennan (University of Oxford, UK)

Find out more from the SMR

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.